NATL HEALTH INVESTORS INC (NHI) Fundamental Analysis & Valuation

NYSE:NHI • US63633D1046

Current stock price

85.17 USD
-0.34 (-0.4%)
At close:
85.17 USD
0 (0%)
After Hours:

This NHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHI Profitability Analysis

1.1 Basic Checks

  • In the past year NHI was profitable.
  • NHI had a positive operating cash flow in the past year.
  • In the past 5 years NHI has always been profitable.
  • Each year in the past 5 years NHI had a positive operating cash flow.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • NHI has a better Return On Assets (5.08%) than 93.50% of its industry peers.
  • NHI has a better Return On Equity (9.33%) than 82.93% of its industry peers.
  • NHI has a Return On Invested Capital of 5.56%. This is amongst the best in the industry. NHI outperforms 95.12% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NHI is above the industry average of 3.11%.
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROIC 5.56%
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • NHI has a Profit Margin of 37.80%. This is amongst the best in the industry. NHI outperforms 91.87% of its industry peers.
  • NHI's Profit Margin has declined in the last couple of years.
  • NHI's Operating Margin of 50.74% is amongst the best of the industry. NHI outperforms 93.50% of its industry peers.
  • In the last couple of years the Operating Margin of NHI has declined.
  • With an excellent Gross Margin value of 80.86%, NHI belongs to the best of the industry, outperforming 82.11% of the companies in the same industry.
  • NHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NHI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHI is destroying value.
  • The number of shares outstanding for NHI has been increased compared to 1 year ago.
  • The number of shares outstanding for NHI has been increased compared to 5 years ago.
  • The debt/assets ratio for NHI has been reduced compared to a year ago.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.11 indicates that NHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of NHI (2.11) is better than 95.12% of its industry peers.
  • A Debt/Equity ratio of 0.76 indicates that NHI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NHI (0.76) is better than 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACC0.72
WACC7.74%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that NHI should not have too much problems paying its short term obligations.
  • The Current ratio of NHI (1.19) is better than 65.04% of its industry peers.
  • NHI has a Quick Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • NHI's Quick ratio of 1.19 is fine compared to the rest of the industry. NHI outperforms 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NHI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.34% over the past year.
  • Measured over the past years, NHI shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.07% on average per year.
  • The Revenue has grown by 12.07% in the past year. This is quite good.
  • Measured over the past years, NHI shows a small growth in Revenue. The Revenue has been growing by 2.45% on average per year.
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%

3.2 Future

  • Based on estimates for the next years, NHI will show a small growth in Earnings Per Share. The EPS will grow by 3.45% on average per year.
  • The Revenue is expected to grow by 14.69% on average over the next years. This is quite good.
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue Next Year17.84%
Revenue Next 2Y13.34%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. NHI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.20, the valuation of NHI can be described as expensive.
  • 67.48% of the companies in the same industry are more expensive than NHI, based on the Price/Earnings ratio.
  • NHI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.70.
  • NHI is valuated quite expensively with a Price/Forward Earnings ratio of 25.29.
  • NHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. NHI is cheaper than 86.18% of the companies in the same industry.
  • NHI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.2
Fwd PE 25.29
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NHI is valued a bit more expensive than 79.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.45
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NHI does not grow enough to justify the current Price/Earnings ratio.
  • NHI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y3.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NHI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.30%, NHI is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.24, NHI has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, NHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.3%

5.2 History

  • The dividend of NHI decreases each year by -3.59%.
  • NHI has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of NHI decreased in the last 3 years.
Dividend Growth(5Y)-3.59%
Div Incr Years0
Div Non Decr Years2
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • NHI pays out 119.52% of its income as dividend. This is not a sustainable payout ratio.
DP119.52%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHI Fundamentals: All Metrics, Ratios and Statistics

NATL HEALTH INVESTORS INC

NYSE:NHI (3/13/2026, 8:04:00 PM)

After market: 85.17 0 (0%)

85.17

-0.34 (-0.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners73.45%
Inst Owner Change-0.55%
Ins Owners0.9%
Ins Owner Change14.89%
Market Cap4.12B
Revenue(TTM)375.63M
Net Income(TTM)141.98M
Analysts76.67
Price Target87.34 (2.55%)
Short Float %2.87%
Short Ratio5.16
Dividend
Industry RankSector Rank
Dividend Yield 4.3%
Yearly Dividend3.61
Dividend Growth(5Y)-3.59%
DP119.52%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.3%
Max EPS beat(2)-1.91%
EPS beat(4)1
Avg EPS beat(4)-1.5%
Min EPS beat(4)-8.3%
Max EPS beat(4)4.29%
EPS beat(8)4
Avg EPS beat(8)0.17%
EPS beat(12)6
Avg EPS beat(12)2.26%
EPS beat(16)7
Avg EPS beat(16)-10.94%
Revenue beat(2)2
Avg Revenue beat(2)8.55%
Min Revenue beat(2)5.78%
Max Revenue beat(2)11.32%
Revenue beat(4)4
Avg Revenue beat(4)6.17%
Min Revenue beat(4)3.26%
Max Revenue beat(4)11.32%
Revenue beat(8)8
Avg Revenue beat(8)5.58%
Revenue beat(12)11
Avg Revenue beat(12)4.1%
Revenue beat(16)12
Avg Revenue beat(16)1.1%
PT rev (1m)0%
PT rev (3m)-0.44%
EPS NQ rev (1m)-2.52%
EPS NQ rev (3m)-2.52%
EPS NY rev (1m)0%
EPS NY rev (3m)1.75%
Revenue NQ rev (1m)2.26%
Revenue NQ rev (3m)4.46%
Revenue NY rev (1m)2.58%
Revenue NY rev (3m)7.48%
Valuation
Industry RankSector Rank
PE 28.2
Fwd PE 25.29
P/S 10.97
P/FCF N/A
P/OCF 17.42
P/B 2.71
P/tB 2.71
EV/EBITDA 19.45
EPS(TTM)3.02
EY3.55%
EPS(NY)3.37
Fwd EY3.95%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)4.89
OCFY5.74%
SpS7.76
BVpS31.44
TBVpS31.44
PEG (NY)2.44
PEG (5Y)N/A
Graham Number46.22
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.6%
ROICexgc 5.62%
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
FCFM N/A
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
ROICexc(3y)5.81%
ROICexc(5y)5.5%
ROICexgc(3y)5.84%
ROICexgc(5y)5.53%
ROCE(3y)7.29%
ROCE(5y)6.89%
ROICexgc growth 3Y6.24%
ROICexgc growth 5Y-1.2%
ROICexc growth 3Y6.24%
ROICexc growth 5Y-1.17%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 363.26%
Cap/Sales 78.28%
Interest Coverage 3.7
Cash Conversion 87.12%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 2.11
F-Score5
WACC7.74%
ROIC/WACC0.72
Cap/Depr(3y)218.38%
Cap/Depr(5y)144.44%
Cap/Sales(3y)46.96%
Cap/Sales(5y)31.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%
Revenue Next Year17.84%
Revenue Next 2Y13.34%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%
EBIT growth 1Y1.11%
EBIT growth 3Y10%
EBIT growth 5Y-3.26%
EBIT Next Year58.98%
EBIT Next 3Y18.87%
EBIT Next 5YN/A
FCF growth 1Y-215.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3Y8.48%
OCF growth 5Y0.38%

NATL HEALTH INVESTORS INC / NHI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NATL HEALTH INVESTORS INC (NHI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NHI.


What is the valuation status for NHI stock?

ChartMill assigns a valuation rating of 2 / 10 to NATL HEALTH INVESTORS INC (NHI). This can be considered as Overvalued.


How profitable is NATL HEALTH INVESTORS INC (NHI) stock?

NATL HEALTH INVESTORS INC (NHI) has a profitability rating of 7 / 10.


What are the PE and PB ratios of NATL HEALTH INVESTORS INC (NHI) stock?

The Price/Earnings (PE) ratio for NATL HEALTH INVESTORS INC (NHI) is 28.2 and the Price/Book (PB) ratio is 2.71.


Is the dividend of NATL HEALTH INVESTORS INC sustainable?

The dividend rating of NATL HEALTH INVESTORS INC (NHI) is 4 / 10 and the dividend payout ratio is 119.52%.